MCRM
JNJ icon

Midway Capital Research & Management’s Johnson & Johnson JNJ Stock Holding History

Midway Capital Research & Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.23M Buy
8,770
+86
+1% +$20K 1.77% 22
2026
Q1 		$2.12M Buy
8,684
+27
+0.3% +$6.29K 2% 21
2025
Q4 		$1.79M Buy
+8,657
New +$1.71M 1.75% 25

Other funds holding JNJ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Midway Capital Research & Management's JNJ Position: Q2 2026 in Review

Midway Capital Research & Management increased its Johnson & Johnson (JNJ) stake by 0.99% in Q2 2026, buying an estimated $20K and bringing the position to 8,770 shares worth $2.23M. The position accounts for 1.77% of the portfolio, ranked #22.

Midway Capital Research & Management first reported a position in JNJ in Q4 2025 and has held it in 3 quarters since. 4,649 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Midway Capital Research & Management held 8,770 shares of Johnson & Johnson worth $2.23M as of Q2 2026.
  • Midway Capital Research & Management bought 86 Johnson & Johnson shares in Q2 2026, an estimated $20K.
  • Johnson & Johnson made up 1.77% of Midway Capital Research & Management's portfolio in Q2 2026, its #22 holding.
  • Midway Capital Research & Management first reported a position in Johnson & Johnson in Q4 2025 and has held it in 3 quarters since.
  • 4,649 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Midway Capital Research & Management's 13F filing for Q2 2026, filed 14 Jul 2026.